X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (182) 182
oncology (153) 153
index medicus (107) 107
female (99) 99
male (84) 84
adult (80) 80
middle aged (76) 76
cancer (66) 66
aged (58) 58
carcinoma, renal cell - drug therapy (56) 56
kidney neoplasms - drug therapy (55) 55
carcinoma, renal cell (50) 50
metastasis (50) 50
renal cell carcinoma (49) 49
sunitinib (46) 46
kidney neoplasms - pathology (43) 43
antineoplastic agents - therapeutic use (42) 42
care and treatment (40) 40
chemotherapy (37) 37
sorafenib (37) 37
prognosis (36) 36
treatment outcome (35) 35
carcinoma, renal cell - pathology (33) 33
research (32) 32
survival (32) 32
disease-free survival (29) 29
animals (28) 28
interferon-alpha (28) 28
aged, 80 and over (27) 27
analysis (27) 27
kidney cancer (27) 27
carcinoma (26) 26
expression (26) 26
hematology, oncology and palliative medicine (26) 26
endothelial growth-factor (25) 25
mice (25) 25
therapy (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
tumors (22) 22
gene expression (21) 21
urology (21) 21
breast cancer (20) 20
kinases (20) 20
drug therapy (19) 19
niacinamide - analogs & derivatives (19) 19
trial (19) 19
bevacizumab (18) 18
bone marrow cells (18) 18
carcinoma, renal cell - mortality (18) 18
health aspects (18) 18
neoplasm metastasis (18) 18
ovarian cancer (18) 18
angiogenesis (17) 17
antineoplastic agents - adverse effects (17) 17
carcinoma, renal cell - secondary (17) 17
kidney neoplasms - mortality (17) 17
stem cells (17) 17
survival analysis (17) 17
cell biology (16) 16
development and progression (16) 16
genetic aspects (16) 16
medical prognosis (16) 16
renal cell cancer (16) 16
review (16) 16
risk factors (16) 16
urology & nephrology (16) 16
bone marrow transplantation (15) 15
pharmacology & pharmacy (15) 15
proteins (15) 15
retrospective studies (15) 15
vascular endothelial growth factor (15) 15
antimitotic agents (14) 14
antineoplastic agents (14) 14
breast-cancer (14) 14
double-blind (14) 14
efficacy (14) 14
everolimus (14) 14
medicine & public health (14) 14
renal cancer (14) 14
tyrosine kinase inhibitor (14) 14
tyrosine kinase inhibitors (14) 14
base sequence (13) 13
cancer therapies (13) 13
child (13) 13
colorectal cancer (13) 13
indoles - therapeutic use (13) 13
medicine, research & experimental (13) 13
mutation (13) 13
phenylurea compounds (13) 13
pyrroles - therapeutic use (13) 13
targeted therapy (13) 13
adolescent (12) 12
biochemistry & molecular biology (12) 12
cancer research (12) 12
gene (12) 12
growth (12) 12
management (12) 12
molecular sequence data (12) 12
neoplasm staging (12) 12
patient outcomes (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2015, Volume 26, Issue suppl 4, pp. iv45 - iv45
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 286 - 296
Journal Article
British Journal of Cancer, ISSN 0007-0920, 1994, Volume 69, Issue 3, pp. 463 - 467
The inhibitory effect of c-myb antisense oligodeoxynucleotides (ODNs) conjugated to folic acid (FA) on HL-60 cell proliferation was examined. Folic acid was... 
GENE | INVIVO | ONCOLOGY | DNA | MEMBRANE | OLIGOMER COMPLEMENTARY | RECEPTOR | DIFFERENTIATION | EXPRESSION | FOLATE | DELIVERY
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9807, pp. 1931 - 1939
Journal Article
Anticancer Research, ISSN 0250-7005, 09/2015, Volume 35, Issue 9, pp. 4575 - 4584
Journal Article
Nature Medicine, ISSN 1078-8956, 08/2012, Volume 18, Issue 8, pp. 1254 - 1261
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs) confirmed to be naturally... 
MEDICINE, RESEARCH & EXPERIMENTAL | PULSED DENDRITIC CELLS | COLONY-STIMULATING FACTOR | HIGH-FREQUENCIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MELANOMA PATIENTS | RENAL-CELL CARCINOMA | TUMOR-ANTIGEN | CELL BIOLOGY | MYELOID SUPPRESSOR-CELLS | PROSTATE-CANCER | REGULATORY T-CELLS | PEPTIDE VACCINE | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Prognosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Kidney Neoplasms - immunology | Immunotherapy, Active | Male | Lymphocyte Depletion | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Carcinoma, Renal Cell - immunology | Cyclophosphamide - therapeutic use | Kidney Neoplasms - blood | T-Lymphocytes, Regulatory - immunology | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Female | Carcinoma, Renal Cell - drug therapy | Immunosuppressive Agents - pharmacology | Chemokine CCL17 - blood | Immunosuppressive Agents - administration & dosage | Kidney Neoplasms - therapy | Carcinoma, Renal Cell - blood | HLA-A2 Antigen - immunology | Antigens, Neoplasm - immunology | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | T-Lymphocytes, Regulatory - drug effects | Cyclophosphamide - pharmacology | Biomarkers | Carcinoma, Renal Cell - therapy | CD8-Positive T-Lymphocytes - immunology | Kidney Neoplasms - drug therapy | Apolipoprotein A-I - blood | Cancer vaccines | Cyclophosphamide | Polypeptides | Immune response | Dosage and administration | Research | Health aspects | Kidney diseases | Peptides | Gene expression | Medical prognosis | Cancer | Immune system
Journal Article
Journal Article
International Journal of Oncology, ISSN 1019-6439, 04/2015, Volume 46, Issue 4, pp. 1435 - 1443
The most important molecular mechanisms promoting carcinogenesis in patients with diabetes mellitus (DM) include oxidative stress, excessive generation of free... 
Obesity | Insulin resistance | Diabetes | Carcinogenesis | Metabolic disorders | COLORECTAL-CANCER RISK | metabolic disorders | NATURAL-KILLER-CELLS | PLASMA C-PEPTIDE | INSULIN-LIKE | BREAST-CANCER | LUNG-CANCER | carcinogenesis | ONCOLOGY | FACTOR (IGF)-I | IGF-BINDING PROTEIN-3 | diabetes | insulin resistance | obesity | T-CELLS | GROWTH-FACTOR-I | Index Medicus
Journal Article